An Official Website of the United States Government
Company Information:
Name:
CorInnova Incorporated
Address:
7000 Fannin St., Suite 1950-D
Houston, TX 77030-
Houston, TX 77030-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(979) 574-0746
Award Totals:
Award List:
Proactive Modulation of Strain for Ventricular Recovery
Award Year / Program / Phase:
2005 / STTR / Phase I
Agency:
HHS
Research Institution:
TEXAS A&M
Abstract:
DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is a debilitating condition that afflicts nearly 5 million Americans, and it has an increasing incidence. Despite improvements and enormous research efforts (both federally and commercially), pharmacological treatments are… More
Proactive Modulation of Strain for Ventricular Recovery
Award Year / Program / Phase:
2006 / STTR / Phase II
Agency:
HHS
Research Institution:
Texas A&M
Abstract:
DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is a debilitating condition that afflicts nearly 5 million Americans, and it has an increasing incidence. Despite improvements and enormous research efforts (both federally and commercially), pharmacological treatments are… More
SBIR Phase I: Pre-clinical Development of Device to Guide Heart Recovery via Assist and Support
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
Michael R. Moreno, MS
Award Amount:
$100,000.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project is focused on a novel therapy for heart failure that employs device mediated intervention to guide cardiac growth, remodeling, and recovery. The CorInnova device is the first to combine active cardiac assist and passive cardiac support.… More
Development of a Hybrid Dynamic Stent
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Christina Bolch – 979-220-3117
Award Amount:
$148,233.00
Abstract:
DESCRIPTION (provided by applicant): Though drug-eluting stents have successfully reduced restenosis rates in coronary applications, they have not proven as effective in peripheral applications. There is evidence that suggests that restenosis is driven bymechanical factors and that stent placement… More